TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Findings in life sciences reported from Research Hospital
September 9th, 2008
New research, 'Angio-oedema as an unusual tolerable side effect of voriconazole therapy,' is the subject of a report. According to recent research published in the Journal of Medical Microbiology, "Voriconazole (VRC) has not previously been reported to cause angio-oedema. Here, we report a case of angio-oedema associated with VRC therapy." "A 37-year-old woman with relapsing invasive vertebral aspergillosis received intravenous VRC and developed angio-oedema 10 days after starting therapy. This condition rapidly diminished after administration of intravenous antihistaminics and did not necessitate cessation of VRC treatment. The treatment was continued for 6...
Source: TB & Outbreaks Week (2008-09-09)
|
